Molecular Imaging

Latest News

Emerging PET Agent Garners Second FDA Fast Track Designation for Prostate Cancer Imaging
Emerging PET Agent Garners Second FDA Fast Track Designation for Prostate Cancer Imaging

January 24th 2025

In addition to an August FDA fast track designation for PSMA PET imaging in patients with suspected metastasis, the radiopharmaceutical 64Cu-SAR-bisPSMA has earned another fast track designation for imaging of biochemical recurrence.

PET Agent Gets FDA Fast Track Designation for Cardiac AL and ATTR Amyloidosis
PET Agent Gets FDA Fast Track Designation for Cardiac AL and ATTR Amyloidosis

January 22nd 2025

SNMMI Issues New Appropriate Use Criteria for Amyloid PET and Tau PET Imaging
SNMMI Issues New Appropriate Use Criteria for Amyloid PET and Tau PET Imaging

January 8th 2025

Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?
Assessing MACE Risk in Women: Can an Emerging Model with SPECT MPI Imaging Have an Impact?

December 9th 2024

New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging

November 18th 2024

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.